1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Anti-Infective Drug News 10 NOVEMBER 2014

Anti-Infective Drug News 10 NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Push For Ebola Vaccines Likely Not Fast Enough For Current Epidemic
Industry Brief - Pfizer's Trumenba Approved In US For Prevention Of Meningococcal Meningitis B
Industry Brief - C.Difficile Programme Gains US Patent Allowance
Industry Brief - Auspherix Secures Funding To Advance Antibiotic Pipeline
Industry Brief - Affinivax Receives Investment Support From Gates Foundation
Industry Brief - Positive Results From Cellceutix' Brilacidin Phase IIb Study In ABSSSI
Industry Brief - ImevaX Raises Funds To Advance IMX 101 Vaccine Against H. Pylori Infections
Industry Brief - Ruthigen Enrols First Patient In RUT58-60 Phase I/II Trial
Industry Brief - Enrolment Begins In Carbavance Phase III Studies
Industry Brief - Isavuconazole Gains FDA ODD For Invasive Candidiasis
Industry Brief - Heritage’s Rifampin Injection Launched In US
Industry Brief - Janssen Enters Collaboration For Evaluating Sirturo In MDR-TB
Industry Brief - Bavarian Nordic/Janssen Enter Agreement For MVA-BN Ebola Vaccine
Industry Trend Analysis - Olysio's Additional FDA Approval Causes Little Change To Poor Sales Outlook
Industry Brief - Imaxio Secures ANR Grant For OPTIVAC Project
Industry Brief - Immunotech Negotiates With Uldic For Infectious Disease Treatment In Africa
Industry Brief - NanoViricides/USAMRIID To Evaluate Anti-Ebola Drug Candidates
Industry Trend Analysis - Ebola Tablet Vaccine To Ease Burden In Future Outbreaks
Industry Brief - Tekmira Commences Manufacture Of New RNAi Therapeutic For Ebola-Guinea
Industry Trend Analysis - Enanta And AbbVie Each Faced With Pivotal HCV Decisions
Industry Brief - Flublok Vaccine Now FDA-Approved For All Adults
Industry Brief - FDA Approves Updated Prescribing Information For Fluzone High-Dose Vaccine
Industry Brief - Novavax' H7N9 VLP Flu Vaccine Candidate Gains Fast Track Designation
Industry Brief - Scynexis Grants Waterstone Worldwide Rights To SCY-635
Industry Brief - Mylan Launches Nevirapine In US
Industry Brief - IRBP Seeks FDA Breakthrough Status For Remune
Industry Brief - Merck Reports Data From Doravirine Phase IIb Study In Treatment-Naive HIV Patients
Industry Brief - Gilead Seeks FDA Approval For TAF-Based Single-Tablet HIV Regimen
Industry Brief - FDA Accepts BLA For Merck/Sanofi Pasteur's Paediatric Hexavalent Vaccine
Industry Brief - Inovio/MedImmune/Penn Secure Grant To Develop DNA-Based MAbs
Industry Trend Analysis - CSL To Overtake Key Flu Vaccine Players After Acquisition
Industry Brief - Viamet Completes USD60mn Series D Financing; To Spin Out PCA Programme
Industry Brief - FTC Clears Actavis' Acquisition Of Durata

Table Of Contents

Anti-Infective Drug News 10 NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...


Download Unlimited Documents from Trusted Public Sources

HIV AIDS Statistics in South Africa

  • February 2017
    8 pages
  • HIV AIDS  

    Food  

  • South Africa  

View report >

Blood Supply Industry in Namibia and Africa

  • February 2017
    209 pages
  • Health Care Pro...  

    Blood Supply  

    HIV AIDS  

  • Namibia  

    Africa  

    World  

View report >

Influenza Statistics

  • February 2017
    119 pages
  • Influenza  

    Hospital  

View report >

Related Market Segments :

Infectious Disease

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.